High level expression of recombinant human growth hormone in Escherichia coli: crucial role of translation initiation region. 2017

Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
Damghan Branch, Islamic Azad University, Damghan, I.R. Iran.

For high-throughput production of recombinant protein in Escherichia coli (E. coli), besides important parameters such as efficient vector with strong promoter and compatible host, other important issues including codon usage, rare codons, and GC content specially at N-terminal region should be considered. In the current study, the effect of decreasing the percentage of GC nucleotides and optimizing codon usage at N-terminal region of human growth hormone (hGH) cDNA on the level of its expression in E. coli were investigated. Mutation in cDNA of hGH was performed through site-directed mutagenesis using PCR. Then, the mutant genes were amplified and cloned into the expression vector, pET-28a. The new constructs were transformed into the BL21(DE3) strain of E. coli and chemically induced for hGH expression. At the final stage, expressed proteins were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), scanning gel densitometry, and western blot. SDS-PAGE scanning gel densitometry assay and western blot analysis revealed higher expression level of hGH by using the two new expressions constructs (mutant genes vectors with decreasing GC content and optimized-codon usage at N-terminal of cDNA) in comparison with wild gene expression vector. Obtained results demonstrated that decreasing the GC nucleotide content and optimization of codon usage at N-terminal of the hGH cDNA could significantly enhance the expression of the target protein in E. coli. Our results highlight the important role of both 5ยด region of the heterologous genes in terms of codon usage and also GC content on non-host protein expression in E. coli.

UI MeSH Term Description Entries

Related Publications

Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
August 2014, Protein expression and purification,
Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
August 1996, Biochemistry and molecular biology international,
Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
July 1991, Biochimica et biophysica acta,
Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
June 1998, Journal of biotechnology,
Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
March 2017, Bioengineered,
Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
January 1987, Gene,
Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
October 2007, BMC molecular biology,
Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
August 1985, DNA (Mary Ann Liebert, Inc.),
Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
May 1998, Applied and environmental microbiology,
Mahsa Ghavim, and Khalil Abnous, and Fatemeh Arasteh, and Sahar Taghavi, and Maryam Sadat Nabavinia, and Mona Alibolandi, and Mohammad Ramezani
September 2002, Acta pharmacologica Sinica,
Copied contents to your clipboard!